FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

Detalles Bibliográficos
Autores principales: Jia, Yannan, Zhang, Weiguo, Basyal, Mahesh, Chang, Kyung Hee, Ostermann, Lauren, Burks, Jared K., Ly, Charlie, Mu-Mosley, Hong, Zhang, Qi, Han, Xin, Fogler, William E., Magnani, John L., Lesegretain, Arnaud, Zal, Anna A., Zal, Tomasz, Andreeff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244167/
https://www.ncbi.nlm.nih.gov/pubmed/37085610
http://dx.doi.org/10.1038/s41375-023-01897-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244167/
https://www.ncbi.nlm.nih.gov/pubmed/37085610
http://dx.doi.org/10.1038/s41375-023-01897-x

Ejemplares similares